Patent Leaderboard
USPTO Patent Rankings Data through Dec 31, 2025
Home › Combination of anti CD19 antibody with a BCL-2 inhibitor and uses thereof

Combination of anti CD19 antibody with a BCL-2 inhibitor and uses thereof

US Patent 12358983 · Granted Jul 15, 2025

Assignee

Inventors

View full patent text on Google Patents →

More Patents by These Inventors

Pharmaceutical combinations for treating tumor comprising anti-CD19 antibody and2025
Pharmaceutical combinations for treating tumor comprising anti-CD19 antibody and2025
Combinations and uses thereof2025
Combinations and uses thereof2025
Treatment for multiple myeloma (MM)2023
Combinations and uses thereof2022
Combinations and uses thereof2022
Combination of an anti-CD19 antibody and a Bruton's tyrosine kinase inhibitor an2020
Combination of an anti-CD19 antibody and a Bruton's tyrosine kinase inhibitor an2020
Antibodies against notch 32020
Treatment for multiple myeloma (MM)2020
Method for the treament of multiple myeloma or non-hodgkins lymphoma with anti-C2019